Single centre study of pulmonary outcome in post-covid syndrome

Authors

  • Dr. Biswal Pradipta Trilochan , Dr. Nrusingha Charan Dash , Dr. Manoj Kumar Nayak , Dr. Swetapadma Pradhan Author

DOI:

https://doi.org/10.48047/

Keywords:

COVID-19; Post-COVID Syndrome; SARS-CoV-2; Acute Respiratory Distress Syndrome; Long COVID.

Abstract

The novel coronavirus SARS-CoV-2 is responsible for the COVID-19 pandemic, which has jeopardized people's health worldwide. This pandemic posed a hazard that had never been seen before. Although the acute phase of COVID-19 and its immediate respiratory difficulties have received much attention (which is understandable), there is growing concern regarding the chronic symptoms that some individuals continue to experience long after recovering from the initial infection. These symptoms can often be debilitating and can last for a long time after the initial infection has been cleared up. Aim: As a result, this study aimed to investigate the clinical characteristics and outcomes of COVID-19-infected patients hospitalized at our establishment. Materials & methods: Fifty COVID-19 patients hospitalized at the SCB Medical College's sole facility in Cuttack participated in this study. Fifty hospitalized individuals developed lung fibrosis within the designated time range due to COVID-19. Results: Following shortness of breath as the symptom that was reported the most often by COVID-19 patients diagnosed with pulmonary fibrosis on admission (49), cough (45), fever (23), sputum (10) and chest discomfort (8) were the next most frequently reported symptoms. In addition, a few patients developed diarrhoea (3), and one lost their sense of smell (1). Dyspnea was the symptom of COVID-19 reported most often by patients. Treatment in an intensive care unit was required for 83 per cent of patients diagnosed with COVID-19 pulmonary fibrosis. Patients who participated in the COVID19 research with lung fibrosis, smoking, asthma, or acute renal impairment had a significantly increased risk of being admitted to the intensive care unit.
Conclusion: The COVID-19 pandemic has the potential to be lethal due to lung fibrosis. This may result in mortality or a lifelong decline in lung function. The probability that an issue may be avoided or, at the very least, its progression can be slowed down improves with early discovery.

Downloads

Download data is not yet available.

Downloads

Published

2023-10-06